Healthcare Startup Olive AI Sells Off Business Units, Winds Down

Olive AI, a healthcare automation firm once valued at $4 billion, has sold parts of its business to healthcare companies Waystar and Humata Health, as per a company statement. The company, which raised nearly $900 million from investors such as Vista Equity Partners, Dragoneer Investment Group, General Catalyst, and Sequoia Capital, will be winding down its operations.

The move comes amid a war between Square and Cash App at Dorsey's Block. The details of the conflict and its implications on Olive AI's decision to sell off its assets remain unclear. The company's future plans following the wind-down of its business have not been disclosed.

Key takeaways

Olive AI, a healthcare automation company once valued at $4 billion, has sold itself off in pieces to healthcare companies Waystar and Humata Health.
The company will wind down its business, according to a company statement.
Olive AI raised nearly $900 million from investors including Vista Equity Partners, Dragoneer Investment Group, General Catalyst, Sequoia Capital.
The company was involved in a war between Square and Cash App at Dorsey’s Block.

Healthcare Startup Olive AI Sells Off Business Units, Winds Down

Key takeaways

Discussion (0)